Why it was recalled
Defective container: Preferred Pharmaceuticals received a letter from the manufacturer Glenmark, that the blister packs are not fully sealed and tablets falling out. Preferred Pharmaceuticals purchased the finished product and repackaged the product for sale.
Product description
Ondansetron ODT Tablets, USP 4mg, 1x10 unit dose tablets, Mfg: Glenmark Pharmaceuticals Limited, Repackaged by Preferred Pharmaceuticals NDC 68788-8666-01
Lot numbers, UPCs & expiration codes
Lot: J1325J, I1725P, EXP Date: 4/30/2027.
Where it was sold
Natinowide in the USA
What to do if you have this product
- Compare the lot number and expiration date on your package with the codes above.
- Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
- If you have symptoms you think are related, contact your doctor. In an emergency call 911.
- Report side effects to FDA MedWatch at 1-800-FDA-1088.
Recall details
- Recall number
- D-0239-2026
- Classification
- Class II
- Status
- Ongoing
- Recall initiated
- Nov 17, 2025
- FDA report date
- Dec 24, 2025
- Quantity
- 575 1x10 Foil Blister Packs
- Recall type
- Voluntary: Firm initiated
- Recalling firm
- Preferred Pharmaceuticals, Inc.
Original FDA data
Every field from FDA enforcement report D-0239-2026, exactly as published.
Show all FDA fields
- City
- Anaheim
- State
- CA
- Status
- Ongoing
- Country
- United States
- Event ID
- 98141
- Address
- 1250 N Lakeview Ave Ste O
- Code information
- Lot: J1325J, I1725P, EXP Date: 4/30/2027.
- Postal code
- 92807-1801
- Report date
- Dec 24, 2025
- Product type
- Drugs
- Recall number
- D-0239-2026
- Classification
- Class II
- Recalling firm
- Preferred Pharmaceuticals, Inc.
- Product quantity
- 575 1x10 Foil Blister Packs
- Reason for recall
- Defective container: Preferred Pharmaceuticals received a letter from the manufacturer Glenmark, that the blister packs are not fully sealed and tablets falling out. Preferred Pharmaceuticals purchased the finished product and repackaged the product for sale.
- Voluntary / mandated
- Voluntary: Firm initiated
- Product description
- Ondansetron ODT Tablets, USP 4mg, 1x10 unit dose tablets, Mfg: Glenmark Pharmaceuticals Limited, Repackaged by Preferred Pharmaceuticals NDC 68788-8666-01
- Distribution pattern
- Natinowide in the USA
- Recall initiation date
- Nov 17, 2025
- Initial firm notification
- Letter
- Center classification date
- Dec 17, 2025